Updated EMILIA Phase III Trial Results Confirm Increase in Overall Survival
Study: HPV Testing Can Predict Precancers For Nearly Two Decades Following Exam
Kyprolis Demonstrates Overall Response Following FDA Accelerated Approval
Trastuzumab Increases Risks Of Congestive Heart Failure
Breast Density Does Not Raise Breast Cancer Death Rates
Amgen Halts Phase III Trial Of Ganitumab Plus Gemcitabine
Spectral Mammography “Like Color vs. Black & White TV”
Study Reveals Racial Disparities In Surgical Prostate Care
2,000 Breast Cancer Recurrence Biomarker Candidates Discovered
NCI Approved CTEP Trials For the Month of August
FDA Approves Afinitor Tablets For Advanced Breast Cancer
Afinitor Suspension Approved For Rare Pediatric Brain Tumor
FDA Approves Xtandi For Late-Stage Castration-Resistant Prostate Cancer
Trending Stories
- Lei Zheng named executive director of Mays Cancer Center
- Infections are a major cause of death in patients treated with CAR T-cell therapy
Meta-analysis focused on causes of death, excluding relapse, recurrence - In 1971, Chris Lundy had minute odds of survival. He is now the longest living BMT recipient at the Hutch
- Murphy, McKay, Nodora, Ballantyne, Stupack named associate directors at UCSD Moores
- How Beth Carner went from six weeks left to live with stage 4 colon cancer to complete remission
- NCI’s new chief data scientist Warren Kibbe tells us about efforts to get “AI-ready”
“All research now involves data science at some level.”